Why LRMR? Larimar Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
LRMR
$3.94-0.12 (-2.96%)
Market ClosedLast close May 1
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.